NF2 and cancer: Inhibition of the core Hippo pathway components via point mutations and epigenetic alterations are found in subsets of human cancers including mutations in NF2 [141,142,143], MST1/2 [144,145], SAV1 [146], MOB1A/B [147], LATS1 [148,149,150,151,152], and LATS2 [88,153,154,155].